THRX — Theseus Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
- $181.72m
- -$23.40m
- 42
- 36
- 15
- 21
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 1.32 | 8.46 | 245 | 198 |
Prepaid Expenses | ||||
Total Current Assets | 1.38 | 8.57 | 248 | 202 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 0.003 | 0.001 | 0.011 | 4.75 |
Long Term Investments | ||||
Other Long Term Assets | ||||
Total Assets | 1.43 | 8.61 | 251 | 222 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 0.615 | 1.59 | 3.68 | 11.1 |
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 3.98 | 1.59 | 4.5 | 14.8 |
Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | -2.55 | 7.02 | 246 | 208 |
Total Liabilities & Shareholders' Equity | 1.43 | 8.61 | 251 | 222 |
Total Common Shares Outstanding |